CFA
CLB icon

Cahill Financial Advisors’s Core Laboratories CLB Stock Holding History

Cahill Financial Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-390
Closed -$11K – 325
2021
Q3 		$11K Buy
+390
New +$11.9K ﹤0.01% 532

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Cahill Financial Advisors's CLB Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 390 shares — an estimated $11K sold.

Cahill Financial Advisors first reported a position in CLB in Q3 2021 and held it in 1 quarter. The position peaked at $11K in Q3 2021. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • Cahill Financial Advisors reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
  • Cahill Financial Advisors sold 390 Core Laboratories shares in Q4 2021, an estimated $11K.
  • Cahill Financial Advisors first reported a position in Core Laboratories in Q3 2021 and held it in 1 quarter.
  • Cahill Financial Advisors's Core Laboratories position peaked at $11K in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.